List view / Grid view
Filter the results
The FDA has announced its approval of Descovy, a PrEP method therapy, to reduce the risk of HIV-1 infection from sex.
Two pharmaceutical companies have partnered to develop a slow-release drug to treat patients with HIV.
A new clinical trial will determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills.
According to a new report, regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months in people undergoing a short-term pause in their antiretroviral therapy (ART) regimens.
Reforms that have been proposed by the Centers for Medicare and Medicaid Services have sparked comments from officials and companies alike...
A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis...
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...